Inventor · disambiguated record
David M. Lyerly
Also filed as: LYERLY DAVID · LYERLY DAVID M · LYERLY DAVID MAXWELL
22 granted patents·7 pending applications·344 citations·filing 1982–2016
95Inventor score
Top patents by PatentIndex Score
29 records- 0191US8343726B2Device and method for detection of analytesTECHLAB INC·Filed 2005·Granted Jan 1, 2013·14 cites·22 claims
- 0290US6733760B1Recombinant toxin A/toxin B vaccine against Clostridium difficileTECHLAB INC·Filed 2000·Granted May 11, 2004·44 cites·9 claims
- 0389US8541242B2Device and method for detection of analytesBOONE JAMES H·Filed 2011·Granted Sep 24, 2013·9 cites·11 claims
- 0489US4713240AVaccines based on insoluble supportsRESEARCH CORP·Filed 1985·Granted Dec 15, 1987·73 cites·10 claims
- 0587US6939548B2Methods to produce high levels of C. difficile toxinsTECHLAB INC·Filed 2002·Granted Sep 6, 2005·25 cites·16 claims
- 0684US9528105B2Nucleic acid extraction using organic solvents to remove inhibitorsTECHLAB INC·Filed 2015·Granted Dec 27, 2016·4 cites·20 claims
- 0782US4879218AAntibody for C.difficileVIRGINIA TECH INTELL PROP·Filed 1988·Granted Nov 7, 1989·42 cites·34 claims
- 0880US5919463AClostridium difficle toxins as mucosal adjuvantsORAVAX INC·Filed 1995·Granted Jul 6, 1999·65 cites·21 claims
- 0979US7192724B2Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a markerTECHLAB INC·Filed 2001·Granted Mar 20, 2007·13 cites·14 claims
- 1079US4533630AToxins and antibodies of C. difficileWILKINS TRACY D·Filed 1982·Granted Aug 6, 1985·36 cites·38 claims
- 1170US7736858B2Method for distinguishing ulcerative colitis from Crohn's disease by detecting the presence of fecal anit-neutrophil cytoplasmic antibodies (ANCA)TECHLAB INC·Filed 2003·Granted Jun 15, 2010·1 cites·8 claims
- 1270US7560240B2Method for monitoring gastrointestinal inflammation in persons with inflammatory bowel disease(IBD)TECHLAB INC·Filed 2003·Granted Jul 14, 2009·7 cites·3 claims
- 1368US7892762B2Method for diagnosing irritable bowel syndrome and monitoring inflammatory bowel diseaseTECHLAB INC·Filed 2009·Granted Feb 22, 2011·1 cites·14 claims
- 1466US6872540B2Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiaeTECHLAB INC·Filed 2002·Granted Mar 29, 2005·5 cites·15 claims
- 1565US10295535B2Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active diseaseTECHLAB INC·Filed 2012·Granted May 21, 2019·1 cites·12 claims
- 1663US2016370361A1Device and method for detection of analytesTECHLAB INC·Filed 2016·Application pending·0 cites
- 1761US9274112B2Device and method for detection of analytesTECHLAB INC·Filed 2013·Granted Mar 1, 2016·0 cites·7 claims
- 1860US7785818B2Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panelTECHLAB INC·Filed 2003·Granted Aug 31, 2010·3 cites·11 claims
- 1960US2015204875A1Device and method for detection of analytesTECHLAB INC·Filed 2015·Application pending·0 cites
- 2058US10295536B2Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with Clostridium difficile diseaseTECHLAB INC·Filed 2014·Granted May 21, 2019·0 cites·8 claims
- 2158US9133527B2Cell wall protein CwpV (CD0514) as a diagnostic marker for Clostridium difficile ribotype 027TECHLAB INC·Filed 2013·Granted Sep 15, 2015·1 cites·7 claims
- 2253US9470684B2Outer membrane protein 18 as a diagnostic marker for campylobacterTECHLAB INC·Filed 2014·Granted Oct 18, 2016·0 cites·20 claims
- 2352US10196632B2Nucleic acid extraction using organic solvents to remove inhibitorsTECHLAB INC·Filed 2016·Granted Feb 5, 2019·0 cites·20 claims
- 2450US8790880B2Cysteine protease Cwp84 (CD2787) as a diagnostic marker for Clostridium difficileTECHLAB INC·Filed 2012·Granted Jul 29, 2014·0 cites·17 claims
- 2549US2012276060A1Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with clostridium difficile diseaseBOONE JAMES HUNTER·Filed 2012·Application pending·0 cites
- 2649US2012276059A1Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile diseaseBOONE JAMES HUNTER·Filed 2012·Application pending·0 cites
- 2747US2005202042A1Recombinant toxin A and toxin B protein carrier for polysaccharide conjugate vaccinesFiled 2004·Application pending·0 cites
- 2847US2005084910A1Method for measuring FceRII/CD23 IgE receptor in human feces as an indicator of a TH2 predominant immune response involved in gastrointestinal illnessesFiled 2004·Application pending·0 cites
- 2931US2005136495A1Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiaeTECH LAB INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →